Previous close | 2.2500 |
Open | 2.2500 |
Bid | 0.0500 |
Ask | 2.6500 |
Strike | 2.50 |
Expiry date | 2024-06-21 |
Day's range | 2.2500 - 2.2500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.